FBIOP Latest Press Releases

-- January 13, 2026 --

Fortress Biotech and Cyprium Therapeutics Announce U.S. FDA Approval of ZYCUBO (copper histidinate), the First and Only Approved Treatment for Menkes Disease in the United States Globe Newswire 7:45 AM

-- December 15, 2025 --

Fortress Biotech and Cyprium Therapeutics Announce FDA Acceptance of CUTX-101 NDA Resubmission Globe Newswire 8:00 AM

-- November 14, 2025 --

Fortress Biotech Reports Third Quarter 2025 Financial Results and Recent Corporate Highlights Globe Newswire 8:30 AM

-- October 21, 2025 --

Fortress Biotech and Subsidiary Urica Therapeutics Announce First Patients Dosed in Crystalys Therapeutics' Global Phase 3 Trials of Dotinurad for the Treatment of Gout Globe Newswire 8:30 AM

-- October 1, 2025 --

Fortress Biotech and Subsidiary Urica Therapeutics Announce Crystalys Therapeutics' $205 Million Series A Financing Globe Newswire 8:05 AM

Fortress Biotech and Cyprium Therapeutics Announce an Update on the NDA for CUTX-101 Globe Newswire 8:00 AM

-- September 2, 2025 --

Fortress Biotech to Present at the H.C. Wainwright 27th Annual Global Investment Conference Globe Newswire 8:30 AM

Market Data Delayed 15 Minutes

Questions? Feedback?Olark live chat software